Miguel Marin
UNL
47
Coauthors
5
Documentos
5
H-index Scopus
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 2 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Neurología | 3 |
| Medicamento | 3 |
| Farmacología | 2 |
| Inmunología | 1 |
| Inflamación | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Farmacología y terapéutica | 4 |
| Enfermedades | 3 |
| Fisiología humana | 2 |
| Problemas sociales y servicios a grupos | 2 |
| Ingeniería química | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 5 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Antoni Camins | 5 |
| Folch J. | 5 |
| Ettcheto M. | 5 |
| Zárate C.B. | 4 |
| Pedros I. | 4 |
| Auladell C. | 3 |
| Olloquequi J. | 3 |
| Abad S. | 3 |
| Petrov D. | 3 |
| Martínez N. | 2 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Review of the advances in treatment for Alzheimer disease: Strategies for combating β-amyloid protein
OtherAbstract: Introduction Alzheimer disease (AD) is a major neurodegenerative disorder which eventually results iPalabras claves:Alzheimer disease, Amyloid hypotheses, Beta-amyloid, Beta-secretase, Gamma-secretaseAutores:Abad S., Antoni Camins, Ettcheto M., Folch J., Miguel Marin, Olloquequi J., Pedros I., Petrov D.Fuentes:scopusThe role of leptin in the sporadic form of Alzheimer's disease. Interactions with the adipokines amylin, ghrelin and the pituitary hormone prolactin
ReviewAbstract: Leptin (Lep) is emerging as a pivotal molecule involved in both the early events and the terminal phPalabras claves:Alzheimer's disease, amylin, Ghrelin, high-fat diet, hippocampus, insulin receptor, leptin, mTOR, obesity, PGC-1α, prolactinAutores:Abad S., Antoni Camins, Ettcheto M., Folch J., Martínez N., Miguel Marin, Patraca I., Pedros I., Petrov D., Zárate C.B.Fuentes:scopusExperimental models for aging and their potential for novel drug discovery
ReviewAbstract: Background: An interesting area of scientific research is the development of potential antiaging druPalabras claves:aging, Heterogeneous mice model, IGF-1, mTOR, Resveratrol, SAMP8, SirtuinsAutores:Antoni Camins, Auladell C., Busquets O., Casadesús G., Ettcheto M., Folch J., Miguel Marin, Olloquequi J., Pallás M., Sanchez-Lopez E., Zárate C.B.Fuentes:scopusMasitinib for the treatment of mild to moderate Alzheimer's disease
ReviewAbstract: Alzheimer's disease (AD) is a degenerative neurological disorder that is the most common cause of dePalabras claves:ALZHÉIMER, inflammation, masitinib, Neurodegeneration, TauAutores:Abad S., Antoni Camins, Auladell C., Ettcheto M., Folch J., Lazarowski A., Miguel Marin, Olloquequi J., Pedros I., Petrov D., Zárate C.B.Fuentes:scopusAnti-inflammatory role of Leptin in glial cells through p38 MAPK pathway inhibition
ArticleAbstract: Background In the present work, we studied the modulatory effect of Leptin (Lep) against pro-inflammPalabras claves:Caspase-3, Cytochrome-c, Glial cells, iNOS, leptin, p38 MAPKAutores:Antoni Camins, Auladell C., Busquets O., Ettcheto M., Folch J., Martí A., Martínez N., Miguel Marin, Patraca I., Pedros I., Sureda F.X., Zárate C.B.Fuentes:scopus